Eviprostat Combination Tablets DB (Eviprostat Tablets DB® / エビプロスタット配合錠DB)

JPY ¥3,400

Japanese Benign Prostatic Hyperplasia Treatment Agent (Bearberry Extract / Black Poplar Extract / Pasqueflower Extract / Horsetail Extract / Refined Wheat Germ Oil combination). Oral enteric-coated tablets for dysuria, residual urine, and urinary frequency associated with BPH. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Nippon Shinyaku Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥3,128
10 - 19 12% JPY ¥2,992
20 + 18% JPY ¥2,788
SKU: EVI-COMB-TAB Category:

Description

Product Overview / 商品概要

Eviprostat Combination Tablets DB (エビプロスタット配合錠DB)
Generic: Bearberry Extract / Black Poplar Extract / Pasqueflower Extract / Horsetail Extract / Refined Wheat Germ Oil Combination Tablets / オオウメガサソウエキス・ハコヤナギエキス・セイヨウオキナグサエキス・スギナエキス・精製小麦胚芽油配合錠
Therapeutic Category: Benign Prostatic Hyperplasia (BPH) Treatment Agent / 前立腺肥大症治療剤
Manufactured by: Nippon Shinyaku Co., Ltd. / 日本新薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Per tablet: Bearberry Extract 1mg, Black Poplar Extract 1mg, Pasqueflower Extract 1mg, Horsetail Extract 3mg, Refined Wheat Germ Oil 30mg / 1錠中:オオウメガサソウエキス1mg、ハコヤナギエキス1mg、セイヨウオキナグサエキス1mg、スギナエキス3mg、精製小麦胚芽油30mg
Additives: Lactose hydrate, Microcrystalline cellulose, Light anhydrous silicic acid, Corn starch, Croscarmellose sodium, Ascorbyl palmitate, Methacrylic acid copolymer LD, Triethyl citrate, Talc, Hypromellose, Titanium oxide, Macrogol 6000, Carnauba wax / 乳糖水和物、結晶セルロース、軽質無水ケイ酸、トウモロコシデンプン、クロスカルメロースナトリウム、パルミチン酸アスコルビン酸、メタクリル酸コポリマーLD、クエン酸トリエチル、タルク、ヒプロメロース、酸化チタン、マクロゴール6000、カルナウバロウ
Appearance: White, enteric-coated film-coated tablet, identification code: 222
外観: 白色、腸溶性のフィルムコーティング錠、識別コード:222

Indications / 効能効果

EN: Dysuria, residual urine and sensation of residual urine, and urinary frequency associated with benign prostatic hyperplasia
JA: 前立腺肥大に伴う排尿困難、残尿及び残尿感、頻尿

Dosage and Administration / 用法用量

EN: Orally administer 1 tablet per dose, 3 times daily. The dose may be adjusted according to symptoms.
JA: 通常1回1錠、1日3回経口投与する。症状に応じて適宜増減する。

Contraindications / 禁忌

EN:
JA:

Regulatory Information / 規制情報

Approval No.: 22000AMX00484000
Sales Started: July 2008 / 2008年7月
Classification Code: 87259
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10], 500 tablets [10 tablets (PTP) x 50], 1050 tablets [21 tablets (PTP) x 50], 500 tablets [bottle, bulk]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Eviprostat Combination Tablets DB (Eviprostat Tablets DB® / エビプロスタット配合錠DB)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Eviprostat Combination Tablets DB (Eviprostat Tablets DB®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.